EVA
ALLONCA CAMPA
Investigador/a
Instituto Universitario de Oncologia del Principado de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Instituto Universitario de Oncologia del Principado de Asturias (32)
2023
-
Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma
Nature Communications, Vol. 14, Núm. 1
2020
-
Expression of E-cadherin and β-catenin in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas
Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 6, pp. 358-366
-
GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β
Cell Death and Disease, Vol. 11, Núm. 11
-
Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma
Oral Oncology, Vol. 110
-
Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma
Biomedicines, Vol. 8, Núm. 12, pp. 1-14
-
Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas
Cancers, Vol. 12, Núm. 7, pp. 1-15
-
Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications
Cancers, Vol. 12, Núm. 4
-
Tspan1: A novel protein involved in head and neck squamous cell carcinoma chemoresistance
Cancers, Vol. 12, Núm. 11, pp. 1-20
2019
-
Frequent alteration of annexin A9 and A10 in HPV-negative head and neck squamous cell carcinomas: Correlation with the histopathological differentiation grade
Journal of Clinical Medicine, Vol. 8, Núm. 2
-
PD-L1 expression in tumor cells is an independent unfavorable prognostic factor in oral squamous cell carcinoma
Cancer Epidemiology Biomarkers and Prevention, Vol. 28, Núm. 3, pp. 546-554
-
SOX2 expression is an independent predictor of oral cancer progression
Journal of Clinical Medicine, Vol. 8, Núm. 10
-
The emerging role of NANOG as an early cancer risk biomarker in patients with oral potentially malignant disorders
Journal of Clinical Medicine, Vol. 8, Núm. 9
-
The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas
International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266
2017
-
A Novel Role for Nanog As An Early Cancer Risk Marker in Patients with Laryngeal Precancerous Lesions
Scientific Reports, Vol. 7, Núm. 1
-
Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma
Head and Neck, Vol. 39, Núm. 9, pp. 1876-1887
-
Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models
Neoplasia (United States), Vol. 19, Núm. 6, pp. 460-470
2016
-
Expression of the voltage-gated potassium channel Kv3.4 in oral leucoplakias and oral squamous cell carcinomas
Histopathology, Vol. 69, Núm. 1, pp. 91-98
-
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793
-
Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
Oncotarget, Vol. 7, Núm. 21, pp. 30935-30950